Home

Products

Technology

Applications

Investors
	Overview
	Press Releases
	Events & Presentations
	Corporate Governance
	Management
	Board of Directors
	Committee Composition
	Committee Charters
	Business Conduct & Ethics
	Financial Information
	SEC Filings
	Section 16 Filings
	Annual Reports
	Quarterly Reports
	Stock Information
	Analyst Coverage

home

investor relations

analyst coverage

Analyst Coverage

print page | email page

Analyst	Firm	Contact Information
Isaac Ro	Leerink Swann & Company	Isaac.Ro@leerink.com Phone: (212) 277-6040

Helicos Biosciences Corporation is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Helicos Biosciences Corporation's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Helicos Biosciences Corporation or its management. Helicos Biosciences Corporation does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

617-264-1950
investorrelations@helicosbio.com

HLCS (OT) Feb 6, 2012

$0.08 0.01

Quotes delayed at least 20 minutes. Information provided by eSignal.

Email alerts sign-up

Fine-tune the emails you receive from Helicos Biosciences Corporation with specific SEC filing types, news types, and stock price changes. Choose to receive the closing stock price each day, or a summary of stock prices at the end of the week.

Sign-up now

RSS news feed sign-up.

Subscribe to RSS news feeds to automatically be notified of SEC filings and news releases.

Sign-up now

Search Investor Relations.